Evidence map›Paper›PMID 23619337›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2013

1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells.

Wei Zheng, Fariba Tayyari, G A Nagana Gowda, Daniel Raftery, Eric S McLamore, Jin Shi, D Marshall Porterfield, Shawn S Donkin, Brian Bequette, Dorothy Teegarden

Open access · greenAbstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Vitamin D regulation of energy metabolism in cancer.British journal of pharmacology · 2022
    Review
  7. Article
  8. Article
  9. Vitamin D Receptor Is Necessary for Mitochondrial Function and Cell Health.International journal of molecular sciences · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wei ZhengInterdepartmental Nutrition Program, Purdue University, West Lafayette, IN 47906, United States. Electronic address: zheng38@purdue.edu.
Fariba Tayyari
G A Nagana Gowda
Daniel Raftery
Eric S McLamore
Jin Shi
D Marshall Porterfield
Shawn S Donkin
Brian Bequette
Dorothy Teegarden
Purdue University West Lafayette · USUniversity of Maryland, College Park · US

Funding

Advanced Methods in NMR-Based MetabolomicsR01GM085291 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL · 2008 to 2016
$2.7M
Interdisciplinary Cancer Prevention Research Internship ProgramR25CA128770 · NCI · PURDUE UNIVERSITY · PI TEEGARDEN, DOROTHY · 2008 to 2012
$1.5M
NCI NIH HHS R25 CA128770NCI NIH HHS R25CA128770NIGMS NIH HHS 1R01GM085291NIGMS NIH HHS R01 GM085291
6 · The paper itself

Abstract

This study was designed to investigate the impact of 1,25-dihydroxyvitamin D (1,25(OH)2D) on glucose metabolism during early cancer progression. Untransformed and ras-oncogene transfected (ras) MCF10A human breast epithelial cells were employed to model early breast cancer progression. 1,25(OH)2D modified the response of the ras cells to glucose restriction, suggesting 1,25(OH)2D may reduce the ras cell glucose addiction noted in cancer cells. To understand the 1,25(OH)2D regulation of glucose metabolism, following four-day 1,25(OH)2D treatment, metabolite fluxes at the cell membrane were measured by a nanoprobe biosensor, [(13)C6]glucose flux by (13)C-mass isotopomer distribution analysis of media metabolites, intracellular metabolite levels by NMR, and gene expression of related enzymes was assessed. Treatment with 1,25(OH)2D reduced glycolysis as flux of glucose to 3-phosphoglycerate was reduced by 15% (P=0.017) and 32% (P<0.003) in MCF10A and ras cells respectively. In the ras cells, 1,25(OH)2D reduced lactate dehydrogenase activity by 15% (P<0.05) with a concomitant 10% reduction in the flux of glucose to lactate (P=0.006), and reduction in the level of intracellular lactate by 55% (P=0.029). Treatment with 1,25(OH)2D reduced flux of glucose to acetyl-coA 24% (P=0.002) and 41% (P<0.001), and flux to oxaloacetate 33% (P=0.003) and 34% (P=0.027) in the MCF10A and ras cells, respectively, suggesting a reduction in tricarboxylic acid (TCA) cycle activity. The results suggest a novel mechanism involving the regulation of glucose metabolism by which 1,25(OH)2D may prevent breast cancer progression.

Indexed as

Carbon IsotopesCell CycleCell LineCell ProliferationCitric Acid CycleEpithelial CellsGenes, rasGlucoseGlyceric AcidsGlycolysisHumansVitamin D1,25-dihydroxyvitamin D3-phosphoglycerateCarbon IsotopesGlucoseGlyceric AcidsVitamin D1,25-dihydroxyvitamin D1,25-Dihydroxyvitamin D1,25(OH)(2)D3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromideBreast cancerCancer preventionEnergy metabolismGlucoseglucose transporter 1GLUT1hexokinase 2HK2lactate dehydrogenaseLDHmass spectrometryMSMTTNMRnuclear magnetic resonance spectroscopyPBSPDHPDKPEPPGK1phosphate buffered salinephosphoenolpyruvatephosphoglycerate kinase1PKpyruvate dehydrogenasepyruvate dehydrogenase kinasepyruvate kinaserasTCA cycletricarboxylic acid cycleVDRVitamin Dvitamin D receptor

Identifiers

PMID23619337
PMCPMC4009997
OpenAlexW2153077258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.